<DOC>
	<DOCNO>NCT02599922</DOCNO>
	<brief_summary>This non-randomized , open-label , Phase 1/2 study safety efficacy rAAV2tYF-PR1.7-hCNGB3 administer one eye subretinal injection individual achromatopsia cause mutation CNGB3 gene . The primary study endpoint safety secondary study endpoint efficacy .</brief_summary>
	<brief_title>Safety Efficacy Trial AAV Gene Therapy Patients With CNGB3 Achromatopsia</brief_title>
	<detailed_description>This non-randomized , open-label , Phase 1/2 study safety efficacy rAAV2tYF-PR1.7-hCNGB3 administer one eye subretinal injection individual achromatopsia cause mutation CNGB3 gene . The primary study endpoint safety secondary study endpoint efficacy . Subjects enrol sequentially four group . Subjects Groups 1 , 2 3 least 18 year age receive low , middle high dose study agent . Subjects Group 4 least 6 year age receive maximum tolerate dose identified Groups 1 , 2 3 . Safety monitor evaluation ocular non ocular adverse event hematology clinical chemistry parameter . Efficacy parameter include visual acuity , light discomfort testing , color vision , static visual field , ERG , adaptive optic retinal image OCT .</detailed_description>
	<mesh_term>Color Vision Defects</mesh_term>
	<criteria>Inclusion Criteria include : 1 . Retinal disease consistent diagnosis achromatopsia document mutation allele CNGB3 gene ; 2 . At least 18 year age Groups 1 , 2 3 least 6 year age Group 4 ; 3 . Able perform test visual retinal function ; 4 . Visual acuity study eye well 55 ETDRS letter ( Snellen equivalent 20/80 ) base average two examination baseline visit ; 5 . Acceptable laboratory parameter ; 6 . For female childbearing potential : A negative pregnancy test within 2 day administration study agent . Exclusion Criteria include : 1 . Refractive error â‰¥ 8.00 diopter ( spherical equivalent ) myopia study eye ; 2 . Evidence degenerative myopia regardless refractive error study eye ; 3 . Preexisting eye condition would contribute vision loss either eye increase risk subretinal injection study eye .</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>